Finnish software developer Combinostics will demo its cNeuro 2.0 artificial intelligence (AI) software at the RSNA 2021 meeting in Chicago.
The new release is able to send segmentation DICOM images from the company's cMRI application, in addition to reports, directly to PACS. It also offers additional report file formats (JPG and PDF), an improved cortical atrophy index, and streamlined installation.
The firm is also demoing its cARIA and cPET works-in-progress: cARIA helps with the management of patients on disease-modifying drugs for Alzheimer's disease by monitoring for the occurrence of amyloid-related imaging abnormalities (ARIA).
Combinostics' cPET supports radiologists with fully automated quantification of FDG and amyloid PET tracers and compares the results with tracer-specific normative data. The software also integrates cMRI segmentations when available to provide better quantification of all brain regions, including small structures such as the hippocampus, the firm said.
